To Look for a Needle in a Haystack: the Search for Autoantibodies in Multiple Sclerosis
Overview
Affiliations
The search for autoantibodies in multiple sclerosis (MS) has been challenging for the last 3 decades. With the development of new proteomic methods and advances in expression and assay technologies, progress in the identification of MS autoantibodies has been made. A number of MS-specific autoantibodies have been proposed, most of them targeting proteins expressed in oligodendrocytes and along the myelin sheath. In this review, we summarize the status of antibody research in MS and then discuss recent developments and future strategies in defining and characterizing the potential antigenic targets of autoantibodies in MS.
DiCillo E, Kountikov E, Zhu M, Lanker S, Harlow D, Piette E J Clin Invest. 2025; 135(5).
PMID: 40026247 PMC: 11870742. DOI: 10.1172/JCI171948.
Perdaens O, van Pesch V Int J Mol Sci. 2024; 25(23.
PMID: 39684351 PMC: 11641818. DOI: 10.3390/ijms252312637.
Carmona S, Aghzadi J, Vincent T, Labauge P, Carra-Dalliere C, Lehmann S Inflammation. 2024; .
PMID: 39641859 DOI: 10.1007/s10753-024-02205-0.
Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept.
Hoftberger R, Lassmann H, Berger T, Reindl M Nat Rev Neurol. 2022; 18(11):681-688.
PMID: 35970870 DOI: 10.1038/s41582-022-00700-2.
Multiple Sclerosis: Therapeutic Strategies on the Horizon.
Manjunatha R, Habib S, Sangaraju S, Yepez D, Grandes X Cureus. 2022; 14(5):e24895.
PMID: 35706718 PMC: 9187186. DOI: 10.7759/cureus.24895.